A 60
Listeria monocytogenes CNS infection treatment meropenem
Listeria monocytogenes meningitis treatment ampicillin
| Parameter | Result | Interpretation |
|---|---|---|
| Colour | Colourless | Normal appearance |
| Appearance | Clear | No turbidity |
| Blood | Absent | |
| Cobweb | Absent | Against TB |
| Total Cell Count | 15 cells/mm³ | Mild pleocytosis |
| Polymorphs | 20% | |
| Lymphocytes | 80% | Lymphocytic predominance |
| RBCs | Few |
| Parameter | Result | Reference | Interpretation |
|---|---|---|---|
| CSF Sugar | 122 mg/dL | 40-70 | Elevated - unusual |
| CSF Protein | 35.6 mg/dL | 8-32 | Mildly elevated |
| Test | Result |
|---|---|
| Gram Stain | Gram positive bacilli seen |
| ZN Stain | Acid fast bacilli NOT seen |
| Culture (48h) | Scanty growth - Listeria monocytogenes |
| Benzylpenicillin | Susceptible |
| Trimethoprim/Sulfa | Susceptible |
| Meropenem | Sensitive (MIC 0.25) |
| Antibiotic | Recommendation |
|---|---|
| Ampicillin 2g IV q4h | First-line - drug of choice |
| + Gentamicin | Add if meningitis/encephalitis (synergy); caution with renal function |
| TMP/SMX | Alternative if penicillin allergy (5 mg/kg TMP component IV q6-8h) |
| Meropenem | Sensitive (MIC 0.25) - usable as salvage/if ampicillin not tolerated |
| Avoid cephalosporins | Inherently resistant (e.g., ceftriaxone NOT active against Listeria) |
| Avoid vancomycin | Not effective even if in vitro susceptibility shown |
Create a quick antibiotic dosing reference for Listeria CNS management
Listeria CNS Dosing Reference
Word Document · DOCX
| Drug | Dose | Frequency |
|---|---|---|
| Ampicillin (1st line) | 2 g IV | q4h |
| + Gentamicin (synergy) | 2 mg/kg load → 1.7 mg/kg IV | q8h (renally adjusted) |
| Gentamicin intraventricular (Ommaya) | 5 mg preservative-free | Once daily via shunt |
| TMP/SMX (PCN allergy) | 5 mg/kg (TMP) IV | q6-8h |
| Meropenem (salvage) | 2 g IV | q8h |